/compare — side-by-sideLOADING

compare stocks // side-by-side, from filings

Compare any stocks, on the real numbers

Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.

Metric	AGLagilon health, inc.
Last close	$87.79close 2026-11-03
Change %	+1.34%close 2026-11-03
Market cap	$1.5Bclose 2026-11-03
P/E	no EPS filed
Revenue	$5.9B ⊙ EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenueFromContractWithCustomerExcludingAssessedTax As ofFY ending 2025-12-31 Filing10-K · 0001628280-26-011655 · filed 2026-02-25 Open the filing on EDGAR →Open the XBRL payload → Citeagilon health, inc. (AGL), us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax: 5,932,576,000 USD, fiscal year ended 2025-12-31. Form 10-K, accession 0001628280-26-011655, filed 2026-02-25. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001831097/us-gaap/RevenueFromContractWithCustomerExcludingAssessedTax.json

Share this comparisonSend AGL side-by-side — free, straight from the filings.

Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.